- Companies in proton therapy, spectroscopy, electronic gases, biotech and robotics raised fresh capital
- The funding will support technology development, production expansion, commercialization and supply-chain localization
CAS Ion Application raises nearly 600 million yuan in first round
Hefei-based medical technology company CAS Ion Application (中科离子) has completed its first market-oriented equity financing, raising nearly 600 million yuan ($89.5 million).
The round was jointly backed by Wanneng Capital, CMB International, QHFZ Capital Management, China Capital, China-Belgium Fund, China Fortune-Tech Capital, Orient Renaissance Capital, Capitech and Yinxinggu Capital.
Founded in 2016, CAS Ion Application was established to commercialize technologies developed at the Hefei Institutes of Physical Science under the Chinese Academy of Sciences.
Its core product is a superconducting cyclotron proton therapy system, with its SC240 superconducting proton cyclotron already in mass production and clinical use.
The new funding will support continued R&D of core technologies, market expansion and the commercialization of fusion-derived technologies in nuclear medicine, nuclear energy and other applications.
IAS Analysis nets more than 100 million yuan in Series B
Wuxi-based IAS Analysis (迅杰光远) has raised more than 100 million yuan ($14.9 million) in a Series B round backed by Shenzhen Capital Group, V Fund and Cuiwei Fund.
Founded in 2016, the company develops compact, portable near-infrared spectrometers and rapid-testing services for food testing, healthcare, environmental monitoring, semiconductor inspection and other applications.
It has been recognized as a national-level specialized and innovative “Little Giant” company.
The funding will support development of a next-generation spectroscopy analysis platform and production-line expansion, while accelerating penetration into the semiconductor industry and expansion into overseas agricultural markets.
Prochip Group bags several hundred million yuan in pre-Series B round
Shanghai-based electronic bulk-gas supplier Prochip Group (宏芯气体) has received several hundred million yuan in a pre-Series B round led by Jian’an No. 1 Fund, jointly established by JIC Investment and the Anhui New Material Industry Fund.
Wuhan Optics Valley Financial Holdings, Yankuang Capital and Resonance Capital, Goertek’s corporate venture arm, also participated.
Founded in 2019, Prochip Group’s core team comes from leading international industrial-gas companies. It provides semiconductor fabs with one-stop gas-station solutions for bulk high-purity gases at parts-per-billion levels.
The new funding will go toward core technology R&D, key project development and the construction of an electronic-gas industry ecosystem, with the aim of accelerating localization of the semiconductor gas supply chain.
Lianwei Chuangyuan secures 160 million yuan in pre-Series A round
Shanghai-based biotech company Lianwei Chuangyuan (联威创元), a subsidiary of listed drugmaker Mabwell, has raised 160 million yuan ($23.86 million) in a pre-Series A round from Huatai Investment, Sincere Capital, Loyal Valley Capital and TopAlliance.
The company serves as Mabwell’s T-cell engager, or TCE, drug-development platform. The financing is accompanied by Mabwell’s transfer of assets related to its TCE programs to Lianwei Chuangyuan.
Following the transaction, Mabwell (迈威生物) is expected to hold a 71.21% stake in Lianwei Chuangyuan and remain its controlling shareholder. Lianwei Chuangyuan will independently pursue global commercialization partnerships for its TCE pipeline.
Juxie Intelligent snags more than 100 million yuan
Wuxi-based robotics component maker Juxie Intelligent (巨蟹智能) has raised more than 100 million yuan ($14.9 million) in a new round led by Huatai Zijin Investment.
Johnson Electric, Segway-Ninebot’s corporate venture capital and X Square Robot participated, while existing investors Nanjing Innovation Capital Group and Ecovacs also increased their investments.
Founded in 2019, Juxie Intelligent was founded by Zhao Wei (赵伟), a PhD from Southeast University. Its core team comes from leading robotics companies and focuses on the in-house development and mass production of key components including harmonic reducers and integrated joint modules.
The new funding will support new product development, equipment purchases and capacity expansion, accelerating scaled delivery of joint modules for humanoid robots.
